…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
crizotinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning crizotinib
5 articles · page 1 of 1…ring may help identify patients who could benefit from extended osimertinib therapy, although further clinical validation is warranted.ctDN…
… discussion, the patient was initiated on targeted therapy with crizotinib, with planned reassessment for surgical resection. This case em…
…d OS of 13.4 months,38 39 leading to full FDA approval in 2024. Adagrasib has also shown modest activity in PDAC (ORR 33%, PFS 5.4 months…
…tients with brain metastases treated with ALK TKIs (brigatinib, crizotinib) were analyzed. Radiomic features were extracted from baseline …